Global Dermatology Markets Set To Grow To $18.5 Billion By 2018

At any one time, one-third of the U.S. population is experiencing at least one active skin condition, and the same is true in countries across the globe. The advent of innovative therapies for some skin diseases has stimulated a strong and renewed interest in this market from major pharmaceutical companies.

BCC Research has published a study to discuss the current size and growth of the dermatology market. According to its report, Skin Disease Treatment Technologies and Global Markets, the global dermatology markets reached $15.8 billion in 2012. The market is expected to reach $16.1 billion in 2013 and $18.5 billion in 2018 for a CAGR of 2.8%.

Use this report to:

• Gain detailed market, technology, and industry analyses of global dermatology markets.
• Receive an overview of the global market for treatments of skin diseases, perhaps the most common of human afflictions.
• Obtain focused coverage of four major categories of skin disease with exceptional medical and commercial significance: dermatitis (allergic and contact), cancers (including melanoma), immune disorders (including psoriasis), and infections (bacterial, fungal, and viral).
• Receive information on various dermatology products and sales forecasts by product categories.
• Discuss the evolution of the market, including the rising prevalence of some skin diseases, and new diagnostic and treatment options.
• Examine the global market by product categories, such as anti-allergic products, antibacterials, antifungals, antivirals, immunotherapies, and anticancers.
• Receive information on industry structure and R&D trends and their likely effects on market potential on a country-by-country basis.

To order your copy of this report or to download the complimentary introduction chapter, click here.

RSS Feeds – Pharmaceuticals